MyAverix Finance
US · Healthcare
Abattis Bioceuticals Corp (ATTBF)
Drug Manufacturers - Specialty & Generic
Abattis Bioceuticals Corp (ATTBF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ATTBF
Abattis Bioceuticals Corp (ATTBF) — FAQ
What is ATTBF's P/E ratio?
The price-to-earnings (P/E) ratio for Abattis Bioceuticals Corp (ATTBF) is 18.00 (data as of 2026-03-23).
Does Abattis Bioceuticals Corp pay a dividend?
Dividend yield is not available in the current snapshot for Abattis Bioceuticals Corp (ATTBF). Check the MyAverix Finance app for the latest dividend data.
What sector is Abattis Bioceuticals Corp in?
Abattis Bioceuticals Corp (ATTBF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ATTBF listed on?
ATTBF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.